Press Releases Year None201920182017 Atreca Announces FDA Clearance of Investigational New Drug Application for ATRC-101 December 3, 2019 PDF Version READ MORE Atreca to Present at Two Upcoming Investor Conferences November 14, 2019 PDF Version READ MORE Atreca Reports Third Quarter 2019 Financial Results and Recent Corporate Developments November 12, 2019 PDF Version READ MORE Atreca to Highlight ATRC-101 Preclinical Data at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting November 5, 2019 PDF Version READ MORE Atreca Announces Appointment of Dr. Lindsey Rolfe to its Board of Directors August 26, 2019 PDF Version READ MORE Atreca Reports Second Quarter 2019 Financial Results and Recent Corporate Developments August 13, 2019 PDF Version READ MORE Atreca Further Strengthens Management Team with Appointment of Lisa Decker as Chief Business Officer and Courtney Phillips as General Counsel July 11, 2019 PDF Version READ MORE Atreca Announces Pricing of Initial Public Offering June 19, 2019 PDF Version READ MORE Atreca to Present at the Cowen and Company Annual Health Care Conference March 4, 2019 PDF Version READ MORE Atreca Announces Retirement of Susan Berland and Appoints Herb Cross as Chief Financial Officer February 25, 2019 PDF Version READ MORE Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 11
